| Xu, Ting |
NCT04835870: Zanubrutinib Plus R-CHOP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL |
|
|
| Recruiting | 2 | 78 | RoW | Zanubrutinib, BTK inhibitors, Rituximab, MabThera, Cyclophosphamide, CTX, Doxorubicin, ADM, Vincristine, VCR, Prednisone, Prednisonum | The First Affiliated Hospital of Soochow University | Non-GCB/ABC Diffuse Large B-Cell Lymphoma | 10/25 | 10/25 | | |
| Not yet recruiting | 2 | 80 | RoW | KN026, KN046, XELOX | Peking University Cancer Hospital & Institute | HER2-positive Colorectal Cancer, HER2-positive Biliary Tract Cancer | 12/26 | 12/26 | | |
NCT06241131: The Quality of Recovery From General Anesthesia With Desflurane for Fundus Surgery |
|
|
| Not yet recruiting | 1 | 220 | NA | Desflurane Inhalant Product | Sichuan Provincial People's Hospital | Desflurane Anesthesia, Postoperative Recovery | 12/24 | 09/25 | | |
NCT06205719: Effect of Remazolam on Anesthesia Recovery in Patients Undergoing Fundus Surgery |
|
|
| Not yet recruiting | 1 | 93 | NA | ciprofol, haisco pharmaceutical group, Remazolam, Yichang Humanwell Pharmaceutical Company, Flumazenil, Enwa Pharmaceutical Company, Remifentanil, Yichang Humanwell Yichang Humanwell Pharmaceutical Company | Sichuan Provincial People's Hospital | Remazolam Anesthesia, Postoperative Recovery | 05/25 | 05/26 | | |
NCT06549907: A Biomarker Exploratory Study of Dual Blockade of PD1/PDL1 and CTLA4 and Anti-angiogenic Therapy |
|
|
| Recruiting | N/A | 50 | RoW | Multi-omics testing, MRI | Peking University Cancer Hospital & Institute | MSS Metastatic Colorectal Cancers, MSI Solid Tumors Refractory to PD1/PDL1 Antibody Monotherapy | 09/28 | 09/28 | | |
NCT05347901: Clinical Precise Diagnosis and Treatment in the Kawasaki Disease |
|
|
| Recruiting | N/A | 800 | RoW | Echocardiography, Genomics NGS sequencing | Affiliated Hospital of Nantong University, Children's Hospital of Fudan University Qidong Branch, Second Affiliated Hospital of Nantong University, Jiangsu Hai'an People's Hospital | Kawasaki Disease | 01/24 | 07/24 | | |
PROEM, NCT06225947: Patient-Reported Outcomes for Lemborexant in Chinese Participants With Insomnia |
|
|
| Recruiting | N/A | 200 | RoW | Lemborexant 5 MG, DAYVIGO | Guangdong Provincial People's Hospital, Nanfang Hospital, Southern Medical University | Insomnia | 03/25 | 06/25 | | |
mhGAP, NCT06702410: WHO Mental Health Gap Action Program () for Improving Child Mental and Behavioral Disorder Service Quality in China |
|
|
| Not yet recruiting | N/A | 375 | RoW | mental health gap action program intervention guide (mhGAP-IG) | Sun Yat-sen University, Zhongshan Boai Hospital | Neurodevelopmental Disorders | 02/26 | 02/26 | | |
NCT06354569: Risk Factors and Risk Grading Prediction of Perioperative Respiratory Adverse Events in Children |
|
|
| Recruiting | N/A | 600 | RoW | | Sichuan Provincial People's Hospital | Perioperative Respiratory Adverse Events | 12/24 | 12/24 | | |
